Markets:

Overview

News

Currencies

International

Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

47.42 -1.03 (-2.13%)

Official Closing Price Updated: 7:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novo Nordisk A/S Common Stock

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

99 100 Next >

Nvidia Just Partnered With A Weight-Loss Giant, But It's Not About Pills ↗

June 12, 2025

Nvidia teams up with Novo Nordisk and IQVIA to boost AI-powered drug development and streamline complex pharmaceutical workflows.

Via Benzinga

4 Dividend Stocks to Double Up on Right Now ↗

June 12, 2025

The stock market is a place where people tend to panic when things go on sale. Instead, buy the dip on these four fabulous dividend winners.

Via The Motley Fool

Topics Artificial Intelligence

2 Unstoppable Stocks to Consider Buying, Even Amid Market Volatility ↗

June 12, 2025

Via The Motley Fool

Topics Artificial Intelligence Government

Should You Buy UnitedHealth Stock Instead of Novo Nordisk Stock? ↗

June 12, 2025

Via The Motley Fool

3 Health Care Stocks With Whale Alerts In Today's Session ↗

May 30, 2025

Via Benzinga

Veru's Enobosarm Shows Muscle In Wegovy Combo Trial ↗

May 28, 2025

Via Benzinga

McDonald's Just Got Hammered By Weight-Loss Drugs — Twice ↗

June 11, 2025

McDonald's faces a potential decline in sales due to the weight loss medications. Other fast-food chains like Domino's and KFC are also at risk, while Taco Bell and Chipotle are better positioned.

Via Benzinga

Nvidia Extends AI Reach In Europe With Alliances ↗

June 11, 2025

Nvidia announced a flurry of alliances with European companies and governments that extend its influence in AI across the continent.

Via Investor's Business Daily

Topics Artificial Intelligence Government

Novo Nordisk’s $812M Deal With Deep Apple Lifts Retail Mood, Chatter Spikes To High Levels ↗

June 11, 2025

Separately, chip-maker Nvidia also announced a collaboration with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases.

Via Stocktwits

Topics Artificial Intelligence Economy

Novo Nordisk, Deep Apple Launch Drug Discovery Alliance For Weight Loss Oral Therapies ↗

June 11, 2025

Novo Nordisk and Deep Apple ink a deal to develop oral therapies targeting a novel GPCR for cardiometabolic diseases, including obesity.

Via Benzinga

Why Novo Nordisk Stock Just Popped ↗

June 10, 2025

Novo Nordisk stock has multiple catalysts that could soon reverse is slide.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

June 10, 2025

Via Benzinga

2 Weight Loss Drug Stocks That Are Screaming Buys in June ↗

June 10, 2025

These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing next-generation offerings.

Via The Motley Fool

Why Novo Nordisk Stock Eked Out a Win on Monday ↗

June 09, 2025

Via The Motley Fool

Obesity Newcomer Metsera, Up 23%, Enters The Ring With A Punch ↗

June 09, 2025

The company is planning to soon begin combination studies, testing two of its drugs in weight loss.

Via Investor's Business Daily

Topics Bankruptcy

Eli Lilly's Obesity Drug Success Spurs Japanese Biotech's Anti-Muscle-Wasting Combo Therapy ↗

June 09, 2025

Chugai plans to pair its muscle-preserving drug with Eli Lilly's orforglipron, addressing muscle loss in obesity care as the market expands rapidly.

Via Benzinga

Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock? ↗

June 08, 2025

Via The Motley Fool

Topics Supply Chain

With Novo Nordisk's CEO Out, Wall Street Wants an American Leader

June 07, 2025

With its stock plummeting over the past year, Novo Nordisk is waving goodbye to its top executive. What might the future hold for the weight-loss drug kingpin?

Via MarketBeat

This Monster Growth Stock Is Up 167% in the Past Year and Disrupting the Healthcare Space ↗

June 07, 2025

Via The Motley Fool

Topics Intellectual Property

The Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching. ↗

June 06, 2025

Amgen is hoping to take on Eli Lilly and Novo Nordisk with a potential monthly shot, MariTide.

Via Investor's Business Daily

Novo Nordisk's Wegovy Tied To Increased Risk Of Rare Vision-Loss Disorder, European Regulators Say ↗

June 06, 2025

Semaglutide drugs now include rare vision risk warning as studies link long-term use to optic neuropathy, macular degeneration, and kidney cancer.

Via Benzinga

Novo Nordisk Stock: Is It Still a Smart Buy? ↗

June 06, 2025

Via The Motley Fool

Should You Invest $1,000 in Eli Lilly today? ↗

June 05, 2025

Via The Motley Fool

What's Going On With Novo Nordisk Shares Today? ↗

June 03, 2025

Shares of Novo Nordisk Inc. (NYSE: NVO) are trading lower Tuesday after a new study raised concerns about a potential link between GLP-1 weight loss drugs like Ozempic and an increased risk of kidney...

Via Benzinga

Florida Rep. Scott Franklin Bought Up to $15K Worth of Union Pacific Stock ↗

June 03, 2025

Via Benzinga

Regeneron's Obesity Trial With Novo Nordisk's Wegovy Hits Lean Target ↗

June 02, 2025

Regeneron highlighted that about 35% of weight loss from semaglutide alone was due to lean mass loss, which combo therapies aim to reduce.

Via Benzinga

NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) – A Strong Growth Stock with Reasonable Valuation ↗

May 31, 2025

NOVO-NORDISK (NYSE:NVO) offers strong growth, solid profitability, and reasonable valuation, making it a compelling choice for investors seeking affordable growth stocks.

Via Chartmill

2 Top Stocks to Buy With Less Than $100 ↗

May 30, 2025

Via The Motley Fool

2 Beaten-Down Stocks to Buy on the Dip ↗

May 30, 2025

Via The Motley Fool

Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly ↗

May 29, 2025

Eli Lilly is rapidly encroaching on Novo Nordisk's yearslong lead in GLP-1 drugs. Can Novo hold its tentpole position?

Via Investor's Business Daily

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Novo Nordisk A/S Common Stock (NY:NVO)

All News about Novo Nordisk A/S Common Stock

Starting at $3.75/week.

Subscribe Today